![]() |
市場調查報告書
商品編碼
1986742
主動脈瓣置換市場報告:按手術類型、產品、最終用途和地區分類(2026-2034 年)Aortic Valve Replacement Market Report by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Sutureless Valve, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2026-2034 |
||||||
2025年全球主動脈瓣置換術市場規模達123億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到271億美元,2026年至2034年的複合年成長率為8.87%。主動脈疾病盛行率的上升、醫療保險系統的擴展以及微創手術(MIS)的日益普及是推動市場成長的關鍵因素。
主動脈瓣置換術是一種外科手術,用於替換心臟中病變或受損的主動脈瓣。通常採用傳統的開胸手術,但也採用微創手術,例如透過較小的胸部切口或經腿部插入導管。此手術用於治療影響瓣膜並控制心臟血流的疾病。它有助於恢復正常的血流,緩解症狀,延長壽命並維持心肌功能。通常建議患有嚴重主動脈瓣疾病(包括主動脈瓣狹窄和主動脈瓣瓣膜閉鎖不全)的患者進行手術,這些疾病通常伴隨胸痛、呼吸困難和疲勞等症狀。
主動脈疾病在一般人群中盛行率的快速成長以及易患此類疾病的老年人口的不斷增加,是全球主動脈瓣置換術需求的主要促進因素。此外,醫療保險體系的日益普及,為主動脈瓣置換術術提供經濟支持並降低醫療成本,也促進了市場成長。同時,人們對主動脈疾病、其症狀和診斷的認知不斷提高,以及主動脈瓣置換術等治療方法的便利性,也對市場產生了積極影響。此外,經導管主動脈瓣置換術(TAVR)的應用也日益廣泛。這是一種微創手術(MIS),無需開胸即可置換主動脈瓣,通常是那些傳統開胸手術風險較高的患者的首選。此外,微創手術具有術中併發症減少、住院時間縮短、疼痛減輕、術後護理負擔減輕、恢復更快以及感染風險降低等優點,因此越來越受到青睞,這也推動了市場成長。此外,將人工智慧 (AI) 和機器學習 (ML) 應用於主動脈瓣置換術的成像技術,以識別併發症高風險患者並最佳化手術流程和術後護理,也促進了市場成長。同時,許多國家政府正採取措施,提供人人可及的高品質醫療服務。這些舉措,加上診斷技術的顯著進步,共同推動了市場成長。
The global aortic valve replacement market size reached USD 12.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 27.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.87% during 2026-2034. The increasing prevalence of aortic diseases, rising implementation of health insurance policies, and the growing adoption of MIS procedures represent some of the key factors driving the market.
Aortic valve replacement is a surgical procedure performed to replace a diseased or damaged aortic valve in the heart. It is usually operated through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter incorporated in the leg. It treats diseases that affect the valves and controls blood flow through the heart. It aids in restoring normal blood flow, reducing symptoms, prolonging life, and preserving the function of the heart muscle. It is generally recommended for patients with severe aortic valve disease, including aortic stenosis or aortic regurgitation, that has symptoms like chest pain, shortness of breath, and fatigue.
The surging prevalence of aortic diseases among the masses and the increasing aging population that is more prone to developing these medical disorders represent one of the major factors driving the demand for aortic valve replacement around the world. Moreover, the rising implementation of health insurance policies that offer financial assistance for aortic valve replacement and reduce medical expenses is favoring the growth of the market. In addition, the growing awareness about aortic diseases, their symptoms, diagnosis, and the easy availability of the treatment options like aortic valve replacement is influencing the market positively. Apart from this, there is an increase in the adoption of transcatheter aortic valve replacement (TAVR), minimally invasive surgical (MIS) procedure that helps replace the aortic valve without open-heart surgery and is generally preferred by patients who are at major risk for traditional open-heart surgery. This, coupled with the rising preferences for MIS procedures on account of fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, and lower risk of infection, is propelling the growth of the market. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in imaging techniques of aortic valve replacement to identify patients who are at higher risk for complications and optimize the procedure and postoperative care is contributing to the market growth. Besides this, governing agencies of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for aortic valve replacement. Some of the factors driving the North America aortic valve replacement market included extensive research and development (R&D) activities, well established healthcare facilities, integration of advanced technologies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global aortic valve replacement market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc, Thubrikar Aortic Valve Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.